Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
05/2010
05/27/2010WO2010020677A3 Protein c variants
05/27/2010WO2010019262A3 Polyvalent vaccine
05/27/2010WO2010018592A3 Lethal gene as a tool for zero background cloning
05/27/2010WO2010014895A3 Nanoparticle compositions for nucleic acids delivery system
05/27/2010WO2010014567A3 Variant hcmv pp65, ie1, and ie2 polynucleotides and uses thereof
05/27/2010WO2010008543A9 Molecular signatures for diagnosing scleroderma
05/27/2010WO2010006286A3 Constructs and libraries comprising antibody surrogate kappa light chain sequences
05/27/2010WO2009155504A3 Methods for the modulation of angiogenesis
05/27/2010WO2009154804A3 Twin fluorophore peptide nucleic acid hybridization probes
05/27/2010WO2009150222A3 Improved protein expression system
05/27/2010WO2009121848A3 Use of pseudomonas aeruginosa alkaline protease (apra) and inhibitors thereof in medicine and agriculture
05/27/2010WO2009061003A3 Nucleic acid complex and nucleic acid delivery composition
05/27/2010WO2009010825A3 D4 desaturases and d5 elongases
05/27/2010WO2009010725A3 Method of assessing the proliferation or differentiation behaviour of a population of target cells in a biological system
05/27/2010WO2003031572A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
05/27/2010WO1990007321A3 Lymphocyte receptor homing sequences and their uses
05/27/2010US20100132072 Method to Increase Crop Grain Yield Utilizing Complementary Paired Growth and Yield Genes
05/27/2010US20100132071 Plants Having Enhanced Yield-Related Traits And A Method For Making The Same
05/27/2010US20100132070 Plant Defense Genes and Proteins and Methods of Use
05/27/2010US20100132069 Pathogen-inducible promoters and their use in enhancing the disease resistance of plants
05/27/2010US20100132068 Cosmid Vector For Plant Transformation And Use Thereof
05/27/2010US20100132060 Therapeuting compositions comprising an rnai agent and a neurotrophic factor and methods of use thereof
05/27/2010US20100132059 Temperature-induced polynucleotides and uses therefor
05/27/2010US20100132056 Germ Cell Marker Using Fish Vasa Gene
05/27/2010US20100131285 Actn3 genotype screen for athletic performance
05/27/2010US20100130729 Mu-1, member of the cytokine receptor family
05/27/2010US20100130728 Taci-immunoglobulin fusion proteins
05/27/2010US20100130595 Antisense oligonucleotides directed against connective tissue growth factor and uses thereof
05/27/2010US20100130590 Deletion bearing bard1 isoforms and use thereof
05/27/2010US20100130589 MODULATION OF eIF4E EXPRESSION
05/27/2010US20100130588 Novel lipid formulations for nucleic acid delivery
05/27/2010US20100130587 METHODS OF TREATING CANCER USING siRNA MOLECULES DIRECTED AGAINST CD24
05/27/2010US20100130586 Diagnosis and treatment of t-cell acute lymphoblastic leukemia
05/27/2010US20100130585 Methods and compositions for investigation and treatment of cancer using a g-protein coupled eicosanoid receptor
05/27/2010US20100130579 Cancer therapy
05/27/2010US20100130449 Use of Tri-Substituted Glycerol Compounds for the Treatment of Radiation Injuries
05/27/2010US20100130419 Artery- and Vein-Specific Proteins and Uses Therefor
05/27/2010US20100130417 Transforming growth factor alpha hii
05/27/2010US20100130414 Methods of Using E2F2 for the Treatment of Hypertension
05/27/2010US20100130410 Neural regeneration peptides and methods for their use
05/27/2010US20100130371 System, method, device, and computer program product for extraction, gathering, manipulation, and analysis of peak data from an automated sequencer
05/27/2010US20100129933 Method for detecting the binding between mdm2 and the proteasome
05/27/2010US20100129931 Anti-Methylation-Controlled J Protein Antibodies and Uses Thereof
05/27/2010US20100129916 Expression of Toxic Genes In Vivo in a Non-Natural Host
05/27/2010US20100129915 Methods for inducing cardiomyogenesis
05/27/2010US20100129914 Tol1 FACTOR TRANSPOSASE AND DNA INTRODUCTION SYSTEM USING THE SAME
05/27/2010US20100129913 Polioma vector expressing long double-stranded rnas
05/27/2010US20100129904 polynucleotide encoding a protein that is non-naturally occurring and has enhanced anti-viral and anti-proliferative activity in comparison to human interferon alpha 2b (HuIFN- alpha 2b); for treating cancer responsive to interferon alpha therapy
05/27/2010US20100129903 Pitx3 expression promoters
05/27/2010US20100129902 Replication Stable and RNase Resistant Chimeras of Pestivirus with Insertion in 3' Nontranslated Region (3'NTR)
05/27/2010US20100129901 Hepatitis c virus vaccine
05/27/2010US20100129892 Process for the preparation of 1,3-propanediol by a recombinant micro-organism in the absence of coenzyme b12 or one of its precursors
05/27/2010US20100129877 Modification of RNA, Producing an Increased Transcript Stability and Translation Efficiency
05/27/2010US20100129869 Methods and compositions for inactivating glutamine synthetase gene expression
05/27/2010US20100129865 Ketose 3-epimerase, its preparation and uses
05/27/2010US20100129864 Novel Bacteriocins, Transport and Vector System and Method of Use Thereof
05/27/2010US20100129863 Optimized core promoters and uses thereof
05/27/2010US20100129862 Novel lipolytic Enzyme lip1
05/27/2010US20100129845 Astaxanthine Biosynthesis in Eukaryotes
05/27/2010US20100129824 Distinguishing pca3 messenger rna species in benign and malignant prostate tissues
05/27/2010US20100129791 cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product
05/27/2010US20100129491 Tryptophan transporter gene and use thereof
05/27/2010US20100129460 Compounds and methods for peptide ribonucleic acid condensate particles for rna therapeutics
05/27/2010US20100129429 Inhibition of autophagy genes in cancer chemotherapy
05/27/2010US20100129405 Isolation, cloning and characterization of new adeno-associated virus (aav) serotypes
05/27/2010US20100129402 Double-effective vaccine vector against foot-and-mouth disease virus (fmdv), methods of preparing and using the same
05/27/2010US20100129399 Linear expression constructs for production of influenza virus particles
05/27/2010US20100129394 Robust Expression of a Bioactive Mammalian Protein in Chlamydomonas Chloroplast
05/27/2010US20100129386 bacterial polypeptides; inflammatory bowel disease (IBD), Crohn's disease and ulcerative colitis; kit comprising the polypeptide immobilized on a solid support
05/27/2010US20100129384 Taci-immunoglobulin fusion proteins
05/27/2010US20100129381 Nucleotide sequences coding fibroblast growth factor-19 specific immunoglobulin for use in prevention and treatment of tumors, cancer and/or cell proliferative disorders
05/27/2010US20100129380 Antibodies Against IL-25
05/27/2010US20100129374 Mammalian Cell Membrane Proteins; Related Reagents
05/27/2010US20100129370 Trefoil Factors and Methods of Treating Proliferation Disorders Using Same
05/27/2010US20100129368 Amino acid sequences that bind to serum proteins in a manner that is essentially independent of the pH, compounds comprising the same, and uses thereof
05/27/2010US20100129364 Combination therapy for the treatment of ocular neovascular disorders
05/27/2010US20100129343 Use Of A Compound For Enhancing The Expression Of Membrane Proteins On The Cell Surface
05/27/2010US20100129323 Novel Shuttle Vector
05/27/2010US20100129318 Cynomolgus il-13 mutein proteins, antibodies, compositions, methods and uses
05/27/2010US20100129313 Kidney-specific tumor vaccine directed against kidney tumor antigen g-250
05/27/2010US20100129288 Gliomedin, Fragments Thereof and Methods of Using Same
05/27/2010CA2781461A1 Transgenic plants and fungi capable of metabolizing phosphite as a source of phosphorus
05/27/2010CA2781197A1 Hiv/siv vaccines for the generation of mucosal and systemic immunity
05/27/2010CA2744495A1 Yeast expressing cellulases for simultaneous saccharification and fermentation using cellulose
05/27/2010CA2744286A1 Fusion collagenase in which affinity tag is linked and method for producing the same
05/27/2010CA2744174A1 Snake factor v and methods of use as a procoagulant
05/27/2010CA2744153A1 Compositions and methods for the assembly of polynucleotides
05/27/2010CA2744114A1 Novel synthetic expression vehicle
05/27/2010CA2743908A1 Nucleic acid quantification products and processes
05/27/2010CA2743880A1 Enzymes and methods for producing omega-3 fatty acids
05/27/2010CA2743778A1 Expression cassettes for seed-enhanced expression in plants
05/27/2010CA2743770A1 Plant defense genes and proteins and methods of use
05/27/2010CA2743634A1 Filamentous fungi with impaired ptrb activity for altered protein production
05/27/2010CA2743229A1 Priming of an immune response
05/27/2010CA2743012A1 Rsv f vlps and methods of manufacture and use thereof
05/27/2010CA2742247A1 Vector comprising multiple homologous nucleotide sequences
05/26/2010EP2189537A1 Detection and treatment of schizophrenia
05/26/2010EP2189534A2 Plants transformed with SYT-polypeptide having increased yield under abiotic stress and a method for making the same
05/26/2010EP2189533A1 Plants having improved characteristics and a method for making the same
05/26/2010EP2189532A1 Promoters from coffee
1 ... 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 1031 ... 4023